How to Prioritize Schizophrenia Care Targets by Cost Drivers
How should clinicians and health systems prioritize schizophrenia management targets based on the main contributors to economic burden?
Patients with schizophrenia generate substantial costs both inside and outside the health care system, and the largest burdens in this analysis were not limited to medication spending. This guide applies to clinicians, practice leaders, and care teams who need to decide where to focus management efforts when trying to reduce real-world burden for patients, caregivers, and systems.
-
Start with the highest-burden domains
Frame schizophrenia management around the study's largest cost categories rather than around pharmacy costs alone. In 2019, excess indirect costs were $251.9 billion, or 73.4% of the total burden, while excess direct health care costs were $62.3 billion and excess direct non-health care costs were $35.0 billion.
-
Prioritize caregiver burden in routine management planning
Recognize caregiving as the single largest cost component identified in the analysis. Caregiving costs were estimated at $112.3 billion, or $28,761 per person with schizophrenia, accounting for 32.7% of the total excess burden; the discussion notes that caregiving needs vary between treatable and treatment-resistant schizophrenia.
-
Target hospitalization reduction before focusing narrowly on medication costs
Use the direct health care breakdown to identify hospitalization prevention as the leading medical target. Inpatient care accounted for $30.2 billion, exceeding outpatient care at $12.9 billion and pharmacy costs at $12.1 billion, with emergency department visits adding another $5.6 billion.
-
Include functional and mortality burden in care priorities
When setting treatment goals, include outcomes tied to unemployment, productivity loss, and premature mortality rather than focusing only on symptom visits and prescriptions. The study estimated excess costs of $77.9 billion for premature mortality, $54.2 billion for unemployment, and $7.4 billion for productivity loss.
-
Coordinate with social and disability systems when planning care
Account for the fact that schizophrenia-related burden extends into law enforcement, homelessness, and disability support systems. Excess direct non-health care costs included $26.1 billion in law enforcement costs, $2.1 billion in homeless shelter costs, and $6.5 billion related to SSI and SSDI.
-
Adjust local planning to payer mix and uncertainty in prevalence
If using these findings for service planning, note that mean excess health care costs differed by insurance type, with the greatest excess among commercially insured patients at $19,293, followed by Medicaid at $15,347 and Medicare at $11,963. Also recognize that the total burden remained large in sensitivity analysis using a lower lifetime prevalence of 0.72%, which still produced an estimated excess burden of $215.1 billion.
Clinical Considerations
- This study is an economic burden analysis and does not test a specific clinical intervention or show that targeting any one cost category will reduce total costs.
- Direct health care costs were estimated in patients with diagnosed schizophrenia or schizoaffective disorder, so costs related to undiagnosed schizophrenia were not captured.
- Definitions of schizophrenia were not consistently available across literature sources used for non-health care and indirect costs, which may under- or overestimate the true burden.
- Generalizability may be limited for people with overlapping insurance eligibility, military coverage, or uninsured populations, and uninsured costs were partly based on assumptions from Medicaid cost ratios.
Bottom Line
If you want to reduce the real-world burden of schizophrenia, focus first on caregiver burden, hospitalization prevention, and functional outcomes, because these outweighed medication costs in this analysis.
